| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Juniper Pharmaceuticals Inc | 243,128 | 1,155,000 | 0.37% | ||
| 2 | DIGIRAD CORP | 334,179 | 1,771,000 | 0.57% | ||
| 3 | AVIRAGEN THERAPEUTICS INC | 2,836,326 | 1,848,000 | 0.60% | ||
| 4 | AMGEN INC | 68,015 | 11,159,000 | 3.60% | ||
| 5 | INVACARE CORP COM | 1,150,629 | 13,692,000 | 4.42% | ||
| 6 | CONMED CORP | 356,304 | 15,823,000 | 5.10% | ||
| 7 | RTI SURGICAL HOLDINGS INC COM | 4,438,950 | 17,756,000 | 5.73% | ||
| 8 | HALYARD HEALTH INC | 584,564 | 22,266,000 | 7.18% | ||
| 9 | MERCK & CO INC | 384,806 | 24,451,000 | 7.88% | ||
| 10 | ORTHOFIX INTL N V | 697,378 | 26,605,000 | 8.58% | ||
| 11 | SUCAMPO PHARMACEUTICALS INCORPORATED CLASS A | 2,803,138 | 30,835,000 | 9.94% | ||
| 12 | UNITED THERAPEUTICS CORP DEL | 234,743 | 31,780,000 | 10.25% | ||
| 13 | ENANTA PHARMACEUTICALS INC | 1,098,524 | 33,835,000 | 10.91% | ||
| 14 | GILEAD SCIENCES INC | 537,021 | 36,474,000 | 11.76% | ||
| 15 | BIOVERATIV INC | 746,445 | 40,651,000 | 13.11% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001609251-17-000006, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
